Projects per year
Fingerprint
Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Therapeutic targeting of IRAK4 in MDS
Verma, A. K. & Starczynowski, D. T.
9/2/22 → 7/31/23
Project: Research project
-
STAT3 inhibition as a therapeutic strategy against MDS stem cells
Verma, A. K., Steidl, U. G., Steidl, U. U. & Verma, A. K.
National Heart, Lung, and Blood Institute
7/23/19 → 6/30/23
Project: Research project
-
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
1/1/19 → 6/30/20
Project: Research project
-
Therapeutic targeting of MDS stem cells
Verma, A. K., Steidl, U. G. & Verma, A. K.
National Heart, Lung, and Blood Institute
8/20/18 → 6/30/22
Project: Research project
-
-
ABCL-038 HIV Status Affects Access to Autologous Stem Cell Transplant in Primary Central Nervous System B-Cell Lymphomas in a Minority Rich, Ethnically Diverse and Socioeconomically Disadvantaged Population at Montefiore Medical Center/Albert Einstein College of Medicine
Narvel, H., Vegivinti, C., Reef, D., Vikash, S., Wang, S., Bazarbachi, A. H., Narvel, A., de Castro, A., Mustafa, J., Khatun, F., Lombardo, A., Nugent, L. T., Gritsman, K., Goldfinger, M., Kornblum, N., Shastri, A., Mantzaris, I., Verma, A. K., Braunschweig, I. & Sica, A., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S354Research output: Contribution to journal › Article › peer-review
-
ABCL-161 Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine
Narvel, H., Yakkali, S., Bazarbachi, A. H., Wang, S., de Castro, A., Narvel, A., Mustafa, J., Khatun, F., Lombardo, A., Gritsman, K., Goldfinger, M., Kornblum, N., Shastri, A., Mcneill, K., Janakiram, M., Mantzaris, I., Verma, A. K., Braunschweig, I. & Sica, R. A., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S362Research output: Contribution to journal › Article › peer-review
-
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
Choudhary, G. S., Pellagatti, A., Agianian, B., Smith, M. A., Bhagat, T. D., Gordon-Mitchell, S., Sahu, S., Pandey, S., Shah, N., Aluri, S., Aggarwal, R., Aminov, S., Schwartz, L., Steeples, V., Booher, R. N., Ramachandra, M., Samson, M., Carbajal, M., Pradhan, K., Bowman, T. V., & 11 others, 2022, In: eLife. 11, e78136.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm
Piszczatowski, R. T., Schwenger, E., Sundaravel, S., Stein, C. M., Liu, Y., Stanley, P., Verma, A., Zheng, D., Seidel, R. D., Almo, S. C., Townley, R. A., Bülow, H. E. & Steidl, U., Nov 7 2022, In: Journal of Experimental Medicine. 219, 11, e20212552.Research output: Contribution to journal › Article › peer-review
Open Access -
AML-351 Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies
Shapiro, L., Mantzaris, I., Shastri, A., Sica, A., Shah, N., Kornblum, N., Gritsman, K., Feldman, E., Verma, A. K., Braunschweig, I., Saunthararajah, Y. & Goldfinger, M., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S241Research output: Contribution to journal › Article › peer-review